This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Male or female, aged 18 years or older.
2. Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
3. Malignant tumor confirmed histologically or cytologically.
Exclusion Criteria:
1. Pregnant or breastfeeding women.
2. Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
3. Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
4. Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
5. Patients with severe organic disease or major organ failure, such as decompensated heart, lung, liver, or kidney failure.
6. Patients with other conditions that, in the investigator's opinion, make them unsuitable for participation in this study.
Primary outcome measure(s)
The incidence of cancer-related fatigue (CRF) in tumor patients. — Baseline The incidence of cancer-related fatigue (CRF) in tumor patients.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.